NO20041607L - Doseringsregime og farmasoytisk preparat for nodprevensjon - Google Patents

Doseringsregime og farmasoytisk preparat for nodprevensjon

Info

Publication number: NO20041607L
Authority: NO; Norway
Prior art keywords: pharmaceutical preparation; dosage regimen; node; prevention; node prevention
Prior art date: 2001-11-27

Application number

NO20041607A

Other languages

English (en)

Other versions

NO333984B1 (no

Inventor

Paul F A Van Look

Illesne Bologh

Katalin Komandi

Laszlo Nemes

Zsolt Szabo

Original Assignee

Richter Gedeon Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-27

Filing date

2004-04-20

Publication date

2004-04-20

2004-04-20 Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet

2004-04-20 Publication of NO20041607L publication Critical patent/NO20041607L/no

2013-11-04 Publication of NO333984B1 publication Critical patent/NO333984B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

NO20041607A 2001-11-27 2004-04-20 Farmasøytisk preparat for nødprevensjon og anvendelse derav. NO333984B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0105173A HU227198B1 (en)	2001-11-27	2001-11-27	Pharmaceutical composition for emergency contraception containing levonorgestrel
PCT/HU2002/000129 WO2003045397A1 (en)	2001-11-27	2002-11-26	Dosage regimen and pharmaceutical composition for emergency contraception

Publications (2)

Publication Number	Publication Date
NO20041607L true NO20041607L (no)	2004-04-20
NO333984B1 NO333984B1 (no)	2013-11-04

Family

ID=89998939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20041607A NO333984B1 (no)	2001-11-27	2004-04-20	Farmasøytisk preparat for nødprevensjon og anvendelse derav.

Country Status (33)

Country	Link
US (1)	US20050288264A2 (no)
EP (1)	EP1448207B1 (no)
JP (1)	JP2005516904A (no)
KR (1)	KR100908161B1 (no)
CN (1)	CN1551774A (no)
AP (1)	AP1849A (no)
AT (1)	ATE293978T1 (no)
AU (1)	AU2002347401A1 (no)
BR (1)	BR0210595A (no)
CA (1)	CA2450359C (no)
DE (1)	DE60203929T2 (no)
DK (1)	DK1448207T3 (no)
EA (1)	EA006545B1 (no)
EC (1)	ECSP045171A (no)
ES (1)	ES2239727T3 (no)
GE (1)	GEP20063882B (no)
HR (1)	HRP20040584B1 (no)
HU (1)	HU227198B1 (no)
IL (1)	IL159394A0 (no)
IS (1)	IS2691B (no)
MA (1)	MA27076A1 (no)
MX (1)	MXPA04005104A (no)
NO (1)	NO333984B1 (no)
NZ (1)	NZ530056A (no)
OA (1)	OA12730A (no)
PL (1)	PL206010B1 (no)
PT (1)	PT1448207E (no)
RS (1)	RS50768B (no)
SI (1)	SI1448207T1 (no)
TN (1)	TNSN04048A1 (no)
UA (1)	UA79942C2 (no)
WO (1)	WO2003045397A1 (no)
ZA (1)	ZA200404114B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2674776A1 (en) *	2006-12-20	2008-07-03	Duramed Pharmaceuticals, Inc.	Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
US20090170823A1 (en) *	2007-12-20	2009-07-02	Duramed Pharmaceuticals, Inc.	Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception
US8512745B2 (en)	2008-12-08	2013-08-20	Laboratoire Hra Pharma	Ulipristal acetate tablets
WO2010066883A1 (en) *	2008-12-12	2010-06-17	Laboratoire Hra-Pharma	A method for contraception
ME02548B (me)	2009-04-14	2017-02-20	Hra Pharma Lab	Postupak za kontracepciju po potrebi
EP3178476A1 (de)	2009-06-23	2017-06-14	Bayer Intellectual Property GmbH	Pharmazeutische zusammensetzung und behandlungsverfahren zur notfallempfängnisverhütung
CN101732324B (zh) *	2009-12-31	2011-12-07	广州朗圣药业有限公司	一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
CN103703014A (zh)	2011-06-01	2014-04-02	埃斯特拉公司	用于产生雌四醇中间体的方法
SI2714712T1 (sl)	2011-06-01	2016-11-30	Estetra S.P.R.L.	Postopek za proizvodnjo intermediatov estetrola
EP2383279A1 (en)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Process for the preparation of estetrol
US9579329B2 (en) *	2011-08-11	2017-02-28	Estetra S.P.R.L.	Use of estetrol as emergency contraceptive
US9579330B2 (en)	2012-11-22	2017-02-28	Bayer Pharma Aktiengesellschaft	Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception
EP2999469A1 (de)	2013-05-23	2016-03-30	Bayer Pharma Aktiengesellschaft	Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen ( on-demand") kontrazeption
CN103877058A (zh) *	2014-03-26	2014-06-25	邵娜	一种左炔诺孕酮片及其制备工艺
SMT201800232T1 (it)	2015-06-18	2018-07-17	Mithra Pharmaceuticals S A	Unita' di dosaggio orodispersibile contenente un componente di estetrolo
HUE054551T2 (hu)	2015-06-18	2021-09-28	Estetra Sprl	Ösztetrolt tartalmazó, szájban diszpergálódó tabletta
MA44205B1 (fr)	2015-06-18	2021-04-30	Estetra Sprl	Comprimé orodispersible comprenant estetrol
EP3310333B1 (en)	2015-06-18	2020-04-29	Estetra SPRL	Orodispersible dosage unit containing an estetrol component
KR102712911B1 (ko)	2016-08-05	2024-10-04	에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼	월경통 및 생리통의 관리방법
JOP20200260A1 (ar)	2018-04-19	2019-10-19	Estetra Sprl	مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	化合物及其用於緩解絕經相關症狀的用途
CN110917154A (zh) *	2019-12-12	2020-03-27	上海信谊天平药业有限公司	一种左炔诺孕酮片的制备方法
TWI893101B (zh)	2020-04-16	2025-08-11	比利時商埃斯特拉有限責任公司	具有降低之副作用之避孕組成物
US20230338355A1 (en) *	2020-07-30	2023-10-26	Acer Therapeutics Inc.	Nk antagonists for contraception
CN119523923A (zh) *	2024-11-21	2025-02-28	华中药业股份有限公司	一种左炔诺孕酮片及其制备方法

2001
- 2001-11-27 HU HU0105173A patent/HU227198B1/hu unknown
2002
- 2002-11-26 IL IL15939402A patent/IL159394A0/xx unknown
- 2002-11-26 AT AT02783334T patent/ATE293978T1/de active
- 2002-11-26 EP EP02783334A patent/EP1448207B1/en not_active Expired - Lifetime
- 2002-11-26 CA CA2450359A patent/CA2450359C/en not_active Expired - Lifetime
- 2002-11-26 UA UA20040504015A patent/UA79942C2/uk unknown
- 2002-11-26 HR HR20040584 patent/HRP20040584B1/xx not_active IP Right Cessation
- 2002-11-26 DK DK02783334T patent/DK1448207T3/da active
- 2002-11-26 KR KR1020047002069A patent/KR100908161B1/ko not_active Expired - Lifetime
- 2002-11-26 EA EA200400731A patent/EA006545B1/ru unknown
- 2002-11-26 JP JP2003546899A patent/JP2005516904A/ja not_active Withdrawn
- 2002-11-26 SI SI200230132T patent/SI1448207T1/xx unknown
- 2002-11-26 PL PL369520A patent/PL206010B1/pl unknown
- 2002-11-26 CN CNA028137523A patent/CN1551774A/zh active Pending
- 2002-11-26 RS YUP-42/04A patent/RS50768B/sr unknown
- 2002-11-26 AU AU2002347401A patent/AU2002347401A1/en not_active Abandoned
- 2002-11-26 ES ES02783334T patent/ES2239727T3/es not_active Expired - Lifetime
- 2002-11-26 GE GE5567A patent/GEP20063882B/en unknown
- 2002-11-26 WO PCT/HU2002/000129 patent/WO2003045397A1/en not_active Ceased
- 2002-11-26 DE DE60203929T patent/DE60203929T2/de not_active Expired - Lifetime
- 2002-11-26 OA OA1200400148A patent/OA12730A/fr unknown
- 2002-11-26 PT PT02783334T patent/PT1448207E/pt unknown
- 2002-11-26 BR BR0210595-0A patent/BR0210595A/pt not_active Application Discontinuation
- 2002-11-26 NZ NZ530056A patent/NZ530056A/en not_active IP Right Cessation
- 2002-11-26 MX MXPA04005104A patent/MXPA04005104A/es active IP Right Grant
- 2002-11-26 AP APAP/P/2004/003046A patent/AP1849A/en active
2003
- 2003-12-05 IS IS7065A patent/IS2691B/is unknown
2004
- 2004-03-26 TN TNP2004000048A patent/TNSN04048A1/en unknown
- 2004-04-20 NO NO20041607A patent/NO333984B1/no not_active IP Right Cessation
- 2004-04-21 MA MA27643A patent/MA27076A1/fr unknown
- 2004-05-26 ZA ZA2004/04114A patent/ZA200404114B/en unknown
- 2004-06-25 EC EC2004005171A patent/ECSP045171A/es unknown
- 2004-10-05 US US10/495,923 patent/US20050288264A2/en not_active Abandoned

Also Published As

Publication number	Publication date
US20050288264A2 (en)	2005-12-29
IS2691B (is)	2010-10-15
EP1448207B1 (en)	2005-04-27
HRP20040584B1 (en)	2012-11-30
DE60203929T2 (de)	2006-01-19
GEP20063882B (en)	2006-07-25
MA27076A1 (fr)	2004-12-20
ES2239727T3 (es)	2005-10-01
AU2002347401A1 (en)	2003-06-10
NO333984B1 (no)	2013-11-04
CA2450359C (en)	2011-05-10
OA12730A (fr)	2006-06-28
ZA200404114B (en)	2005-10-26
TNSN04048A1 (en)	2006-06-01
PL369520A1 (en)	2005-04-18
CN1551774A (zh)	2004-12-01
SI1448207T1 (en)	2005-10-31
HUP0105173A3 (en)	2004-03-29
EA006545B1 (ru)	2006-02-24
HUP0105173D0 (en)	2002-02-28
WO2003045397A1 (en)	2003-06-05
HRP20040584A2 (en)	2005-02-28
MXPA04005104A (es)	2004-08-19
PL206010B1 (pl)	2010-06-30
RS50768B (sr)	2010-08-31
RS4204A (sr)	2007-02-05
ATE293978T1 (de)	2005-05-15
AP2004003046A0 (en)	2004-06-30
HU227198B1 (en)	2010-10-28
KR100908161B1 (ko)	2009-07-16
EA200400731A1 (ru)	2004-12-30
BR0210595A (pt)	2004-06-08
IS7065A (is)	2003-12-05
CA2450359A1 (en)	2003-06-05
HUP0105173A2 (hu)	2003-08-28
AP1849A (en)	2008-05-23
EP1448207A1 (en)	2004-08-25
NZ530056A (en)	2005-02-25
ECSP045171A (es)	2004-08-27
DE60203929D1 (de)	2005-06-02
US20050032755A1 (en)	2005-02-10
DK1448207T3 (da)	2005-06-27
UA79942C2 (en)	2007-08-10
KR20040066088A (ko)	2004-07-23
PT1448207E (pt)	2005-08-31
IL159394A0 (en)	2004-06-01
JP2005516904A (ja)	2005-06-09

Publication	Publication Date	Title
NO20041607L (no)	2004-04-20	Doseringsregime og farmasoytisk preparat for nodprevensjon
NO2023030I1 (no)	2023-08-17	Apixaban and pharmaceutical acceptable salts thereof
NO20033143D0 (no)	2003-07-09	Farmasoytisk preparat
NO20030418D0 (no)	2003-01-27	Nytt farmasöytisk preparat
PT1390063E (pt)	2005-03-31	Forma de dosagem farmaceutica de mesilato de nelfinavir amorfo
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
NO20030627L (no)	2003-04-08	Hydrogel-drevet medikament doseringsform
NO20033785D0 (no)	2003-08-26	Farmasöytisk formulering
NO20043904L (no)	2004-11-11	Oral doseringsform inneholdende en PDE4-hemmer som aktivt ingrediens og polyvinylpyrrolidon som eksipiens
NO20031744D0 (no)	2003-04-15	Nye ikke-imadazolforbindelser og farmasöytisk preparat omfattende slike
NO20032517L (no)	2003-06-20	Farmasöytisk preparat inneholdende amlodipinmaleat
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
NO20033042L (no)	2003-09-04	Cyklodekstrin-inneholdende farmasöytisk preparat
NO20014738L (no)	2001-10-23	Tolperisonholdig farmasöytisk preparat for oral administrering
NO20025805D0 (no)	2002-12-03	Farmasöytisk preparat
IS7266A (is)	2004-05-14	Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
DE60217390D1 (de)	2007-02-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20041485L (no)	2004-04-13	Farmasoytisk formulering omfattende (R)-bicalutamid
DK200300348U4 (da)	2004-04-23	Fast farmaceutisk dosisform omfattende amlodipinmaleat
NO20030156L (no)	2003-03-13	Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
NO20033162D0 (no)	2003-07-10	Farmasoytisk tablett omfattende paroksetinmesylat
NO20021036L (no)	2002-04-26	Farmasöytisk preparat
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung

Legal Events

Date	Code	Title	Description
2023-01-09	MK1K	Patent expired